Mental disorders, treatment response, mortality and serum cholesterol: A new holistic look at old data

Psychiatria Danubina

Volumn 19, Issue 4, 2007, Pages 270-281

  Jakovljević, Miro ^a   Reiner, Željko ^a   Miličić, Davor ^a  

^a KBC Zagreb   (Croatia)

Author keywords

Cholesterol; Coronary heart disease; HDL; LDL; Mental disorders; Mortality; Treatment response

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; CHOLESTEROL; CLOZAPINE; FIBRIC ACID DERIVATIVE; FLUOXETINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; ICOSAPENTAENOIC ACID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; METFORMIN; MEVINOLIN; NEUROLEPTIC AGENT; NICOTINIC ACID; NORTRIPTYLINE; OLANZAPINE; OMEGA 3 FATTY ACID; PHENOTHIAZINE; PLACEBO; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRIACYLGLYCEROL;

ALZHEIMER DISEASE; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; BORDERLINE STATE; BRAIN FUNCTION; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DEATH; DEMENTIA; DEPRESSION; DIET THERAPY; DISEASE ASSOCIATION; DISSOCIATIVE DISORDER; DYSLIPIDEMIA; GENERALIZED ANXIETY DISORDER; HEART DISEASE; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MAJOR DEPRESSION; MEDLINE; MENTAL DISEASE; MORTALITY; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PANIC; PATHOPHYSIOLOGY; PEER REVIEW; PHYSICAL ACTIVITY; POSTTRAUMATIC STRESS DISORDER; PSYCHOPATHY; RELIABILITY; SCHIZOPHRENIA; SIDE EFFECT; SUICIDE; TREATMENT RESPONSE; WEIGHT CHANGE;

BRAIN; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHOLESTEROL; HOLISTIC HEALTH; HUMANS; HYPERCHOLESTEROLEMIA; MENTAL DISORDERS;

EID: 36448990843     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (97)

1. Agargun MY, Dulger H, Inci R, Kara H, Ozer OA, Sekerogly AM & Besirogly L. Serum lipid concentrations in obsessive-compulsive disorder patients with and without panic attacks. Can J Psychiatry 2004; 49:776-778.
2. Almeida-Montes LG, Valles-Sanchez V, Moreno-Aguilar J, Chavez-Balderas RA, Garcia-Marin JA, Cortes Sotres JF & Hheinze-Martin G. Relation of serum cholesterol, lipid, serotonin and tryptophan levels to severity of depression and to suicide attempts. J Psychiatry Neurosience 2000; 25:371-7.
3. Atmaca M, Kuloglu M, Tezcan E & Ustundag B. Serum leptin and cholesterol levels in schizophrenic patients with and without suicide attempts. Acta Psychiatr Scand 2003; 108:208-214.
4. Babić D, Jakovljević M, Martinac M, Šarić M, Topić R & Maslov B. Metabolic syndrome and combat post-traumatic stress disorder intensity: preliminary findings. Psychiatria Danubina 2007; 19:68-75.
5. Benton D: Do low cholesterol levels slow mental processing. Psychosom Med 1995; 57:50-53.
6. Bjorkhem I: Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. Journal of Internal Medicine 2006; 260:493-508.
7. Boston PF, Dursun SM & Reveley MA: Cholesterol and mental disorder. British Journal of Psychiatry 1996; 169:682-689.
8. Canevari L & Clark JB. Alzheimer's disease and cholesterol: The fat connection. Neurochem Res 2007; 32:739-750.
9. Casey DE. Excessive mortality and morbidity associated with schizophrenia. In Meyer JM & Nasrallah HA (eds). Medical Illness and Schizophrenia, 13-34. American Psychiatric Publishing, Inc., Washington 2003.
10. Chen CC, Lu FH, Wu JS & Chang CJ. Correlation between serum lipid concentrations and psychological distress. Psychiatry Research 2001; 102:153-162.
11. Cohn TA & Sernyak MJ. Metabolic monitoring for patients treated with antipsychotic medications. Can J Psychiatry 2006; 51:492-501.
12. Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes: Consensus statement. Diabetes Care 2004; 27:596-601.
13. Cui Y, Blumenthal RS, Flaws JA, Whiteman MK, Langenberg P, Lachorik PS Bush TL. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 2001; 161:1413-1419.
14. Deuschle M, Hamann B, Meichel C, Krumm B, Lederbogen F, Kniest A, Colla M & Heuser I. Antidepressive treatment with amitriptyline and paroxetine: Effects on saliva cortisol concentrations. Journal of Clinical Psychopharmacology 2003; 23:201-205.
15. Durson SM, Szemis A, Andrews H, et. al.. The effects of clozapine on levels of total cholesterol and related lipids in serum of patients with schizophrenia: a prospective study. J Psychiatry Neurosci 1999; 24:453-55.
16. Ellison LF & Morrison HI. Low serum cholesterol concentration and risk of suicide. Epidemiology 2001; 12:168-172.
17. Fagiolini A, Frank E, Scott JA, Turkin S & Kupfer DJ. Metabolic syndrome in bipolar disorder: finding from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disorders 2005; 7:424-430.
18. Francis KT. Psychologic correlates of serum indicators of stress in man: A longitudinal study. Psychosomatic Medicine 1979; 41:617-628.
19. Freedman DS, Byers T, Barret DH, Stroup NE, Eaker E & Monroe-Blum H. Plasma lipid levels and psychologic characteristics in men. Am J Epidemiol 1995; 141:507-517.
20. Gabriel A. Changes in plasma cholesterol in mood disorder patients: Does treatment make a difference? Journal of Affective Disorders 2007; 99:273-278.
21. Ghaemi SN, Shields GS, Hegarty JD & Goodwin FK. Cholesterol levels in mood disorders: high or low? Bipolar Disorders 2000; 2:60-64.
22. Glueck CJ, Tieger M, Kunkel R, Tracy T, Speirs J, Streicher P & Illig E. Improvement in symptoms of depression and in an index of life stressors accompanying treatment of severe hypertriglyceridemia. Biol Psychiatry 1993; 34:240-252.
23. Gimpl G, Burger K & Fahrenholz F. Cholesterol as modulator of receptor function. Biochemistry 1997; 36:10959-10974.
24. Goldstone K & Baillie A. Depression and coronary heart disease: A review of the epidemiological evidence, explanatory mechanisms and management approaches. Clinical Psychology Review (2007), doi:10.1016/j cpr.2007.05.005.
25. Golomb B. Low cholesterol and violence. Arch Intern Med 1995; 155:2485.
26. Graham I, Atar D, Borch-Johnsen K & all. European guidelines on cardiovascular disease prevention in clinical practice: full text. Europ J Cardiovasc Prev Rehabil 2007; 14 (Suppl 2):S1-S113.
27. Hallahan B & Garland M. Essential fatty acids and mental health. The British Journal of Psychiatry 2005; 186:275-277.
28. Hayward C, Taylor CB, Roth WT, King R & Agras WS. Plasma lipid levels in patients with panic disorder or agoraphobia. Am J Psychiatry 1989; 146:917-919.
29. Hoyer S & Riederer P. Alzheimer disease - No target for statin treatment. A mini review. Neurochem Res 2007; 32:695-706.
30. Huang TL, Wu SC, Chiang YS & Chen JF. Correlation between serum lipid, lipoprotein concentrations and anxious state, depressive state or major depressive disorder. Psychiatry Research 2003; 118:147-153.
31. Huang TL & Chen JF. Cholesterol and lipids in depression: stress, hypothalamo-pituitary-adrenocortical axis, and inflammation/immunity. Advances in Clinical Chemistry 2006; 39:81-105.
32. Iribarren C, Reed DM, Chen R, Yano K & Dwyer JH. Low serum cholesterol and mortality: Which is the cause and which is the effect? Circulation 1995; 92:2396-2403.
33. Jacobs D, Blackburn H, Higgins M, Reed D, Iso H, McMillan G, Neaton J, Nelson J, Potter J, Rifkind B, Rossouw J, Shekelle R & Yusuf S. Report of the conference on low blood cholesterol: mortality associations. Circulation 1992; 86:1046-1060.
34. Jakovljević M, Crnčević Ž, Ljubičić D, Topić R & Šarić M. Mental disorders and metabolic syndrome: Fatamorgana or warning reality. Psychiatria Danubina 2007; 19:76-86.
35. Jenkins CD, Hames CG, Zyzanski SJ, Rosenman RH & Friedman M. Psychological traits and serum lipids. Psychosom Med 1969; 31:115-128.
36. Jow GM, Yang TT & Chen CL. Leptin and cholesterol levels are low in major depressive disorder, but high in schizophrenia. Journal of Affective Disorders 2006; 90:21-27.
37. Kagan BL, Leskin G, Haas B, Wilkins J & Foy D. Elevated lipid levels in Vietnam veterans with chronic posttraumatic stress disorder. Biol Psychiatry 1999; 45:374-377.
38. Kaplan JR, Shively CA & Fontenot MB. Demonstration of an association among dietary cholesterol, central serotonergic activity and social behavior in monkeys. Psychosom Med 1994; 56:479-484.
39. Katzeff HL. Hyperlipidemia. In Manu P, Suarez RE & Barnett BJ (eds). Handbook of Medicine in Psychiatry, 429-434. American Psychiatric Publishing, Inc., Washington, 2006.
40. Kim YK & Myint AM. Clinical application of low serum cholesterol as an indicator for suicide risk in major depression. Journal of Affective Disorders 2004; 81:161-166.
41. Kop WJ & Gottdiener JS. The role of immune system parameters in the relationship between depression and coronary artery disease. Psychosomatic Medicine 2005; 67 (suppl 1):s37-s41)
42. Kopf D, Westphal S, Luley CW, Ritter S, Giles M, Weber-Haman B, Lederbogen F, Lehnert H, Henn FA, Heuser I & Deuschle M. Lipid metabolism and insulin resistance in depressed patients - Significance of weight, hypercortisolism, and antidepressant treatment. Journal of Clinical Psychopharmacology 2004; 24:527-531.
43. Kuczmierczyk AR, Barbee JG, Bologna NA & Townsend MH. Serum cholesterol levels in patients with generalized anxiety disorder (GAD) and with GAD and comorbid depression. Can J Psychiatry 1996; 41:465-468.
44. Lacerda ALT, Caetano D & Caetano SC. Cholesterol levels in panic disorder, generalized anxiety disorder and major depression. Arq Neuropsiquiatr 2000; 58 (2-B):408-411.
45. Lindberg G, Rastam L, Gullberg B & Eklund GA. Low serum cholesterol concentration and short term mortality from injures in men and women. Br Med J 1992; 305:277-279.
46. Ljubičić D, Crnčević Ž, Jakovljević M, Topić R, Doričić F & Šarić M. Mental disorders and cholesterolemia: possible relations and explanatory mechanisms underlying cardiovascular comorbidity. Psychiatria Danubina 2008; 20 (in press).
47. Maes J, Delanghe J, Meltzer HY, Scharp'e S, D'Hondt P & Cosyns P. Lower degree of esterification of serum cholesterol in depression: relevance for depression and suicide research. Acta Psychiatr Scand 1994; 90:252-8.
48. Maes M, Smith R, Christophe A, Cosyns P, Desnyder R & Meltzer HY. Fatty acids composition in major depression: decrease omega3 fractions in cholesteryl esters and increased C20omega3-4omega6/C20:5omega3 ratio in cholesteryl esters and phospholipids. Journal of Affective Disorders 1996; 38:35-46.
49. Maes M, Smith R, Christophe A, Vandoolaeghe E, Van Gastel A, Neels H, Demedis P, Wauters A & Meltzer HY. Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed man with serious suicidal attempts: relationship with immune-inflammatory markers. Acta Psychiatr Scand 1997; 95:212-221.
50. Manfredini R, Caracciolo S, Salmi R, Boari B, Tomelli A & Gallerani M. The association of low serum cholesterol with depression and suicidal behaviours: New hypotheses for the missing link. The Journal of International Medical Research 2000; 28:247-257.
51. Marčinko D, Martinac M, Karlović D, Filipčić I, Lončar C, Pivac N, Jakovljević M. Are there differences in serum cholesterol and cortisol concentrations between violent and non-violent schizophrenic male suicide attempters? Coll Antropol 2005; 29:153-7.
52. Marčinko D, Pivac N, Martinac M, Jakovljević M, Mihaljević-Peleš A, Muck-Šeler D. Platelet serotonin and serum cholesterol concentrations in suicidal and non-suicidal male patients with a first episode of psychosis. Psychiatry Res. 2007; 150:105-8. Epub 2007 Jan 31.
53. McCallom J, Simmons I, Simmons J & Friedlander Y. Lower serum cholesterol is not associated with depression in the elderly. Data from an Australian community study. Aust NZ J Med 1994; 24:561-564.
54. McCarron RM & Keenan CR. The metabolic syndrome. In Bermudes RA, Keck PE & McElroy (eds). Managing Metabolic Abnormalities in the Psychiatrically Ill - A Clinical Guide for Psychiatrists, 25-53. American Psychiatric Publishing, Inc., Washington, 2007.
55. Meyer JM. Cardiovascular illness and hyperlipidemia in patients with schizophrenia. In Meyer JM & Nasrallah HA (eds). Medical Illness and Schizophrenia, 53-80. American Psychiatric Publishing, Inc., Washington, 2003.
56. Meyer JM & Koro CE. The effects of antipsychotic therapy on serum lipids: a comprehensive review. Schizophrenia Research 2004; 70:1-17.
57. Moessner R, Mikova O, Koutsilieri E, Saoud M, Ehlis AC, Mueller N, Fallgatter AJ & Riederer P. Consensus paper of the WFSBF Task Force on Biological Markers: Biological markers on depression. The World Journal of Biological Psychiatry 2007; 8:141-174.
58. Morgan RE, Palinkas LA, Barrett-Connor EL & Wingard DL. Plasma cholesterol and depressive symptoms in older men. Lancet 1993; 341:75-79.
59. Muldoon MF, Manuck SB & Matthews KA. Lowering cholesterol concentrations and mortality: A quantitative review of primary prevention trials. Br Med J 1990; 301:309-314.
60. Musselman DL, Evans DL & Nemeroff CB. The relationship between depression to cardiovascular disease. Arch Gen Psychiary 1998; 55:580-592.
61. New AS, Sevin EM, Mitropoulou V, Reynolds D, Novotny SL, Callahan A, Trestman RL & Siever LJ. Serum cholesterol and impulsivity in personality disorders. Psychiatry Research 1999; 85: 145-150.
62. Olusi SO & Fido AA. Serum lipid concentrations in patients with major depressive disorder. Biol Psychiatry 1996; 40:1128-1131.
63. Onuegby AJ, Agbedana EO, Baiyewu O, Olisekodiaka MJ, Ebesunun MO, Adebayo K, Ayelagbe OG & Adegoke OD. Evaluation of plasma lipids and lipoproteins in Nigerians suffering from depressive illness. African Journal of Biomedical Research 2007; 10:133-139.
64. Ormiston T, Wolkowitz OM, Reus VI & Manfredi F. Behavioral implications of lowering cholesterol levels: A double-blind pilot study. Psychosomatics 2003; 44:412-414.
65. Osborn DPJ, Nazareth I & King MB. Risk for coronary heart disease in people with severe mental illness. Brit J Psychiatry 2006; 188:271-277.
66. Pae CU, Kim JJ, Lee SJ, Lee C, Paik IH & Lee CU. Aberration of cholesterol level in first-onset bipolar I patients. Journal of Affective Disorders 2004; 83:79-82.
67. Papakostas GI, Peterson T, Sonawalla SB, Merens W, Iosifescu DV, Alpert JE, Fava M & Nierenberg AA. Serum cholesterol in treatment-resistant depression. Neuropsychobiology 2003; 47:146-151.
68. Papakostas GI, Ongur D, Iosifescu DV, Mischoulon D & Fava M. Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses. European Neuropsychopharmacology 2004; 14:135-142.
69. Papassotiropoulos A, Hawellek B, Frahnert C, Rao GS & Rao ML. The risk of acute suicidality in psychiatric inpatients increases with low plasma cholesterol. Pharmacopsychiatry 1999; 32:1-4.
70. Peet M & Stokes C. Omega-3 fatty acids in the treatment of psychiatric disorders. Drugs 2005; 65:1051-1059.
71. Peter H, Hand I, Hohagen F, Koenig A, Mindermann O, Oeder F & Wittich W. Serum cholesterol level comparison: control subjects, anxiety disorder patients, and obsessive-compulsive disorder patients. Can J Psychiatry 2002; 47:557-561.
72. Pfrieger FW. Cholesterol homeostasis and function in neurons of the central nervous system. Cell Mol Life Sci 2003; 60:1158-1171.
73. Ploeckinger B, Dantendorfer K, Ulm M, Baischer W, Derfler K, Musalek M & Dadak C. Rapid decrease of serum cholesterol concentration and postpartum depression. Br Med J 1996; 313:664-670.
74. Procyshyn RM. Clozapine, triglycerides and clinical effectiveness: A hypothesis. Advances in Pharmacy 2003; 1:223-227.
75. Raffai RL & Weisgraber KH. Cholesterol: from heart attacks to Alzheimer disease. Journal of Lipid Research 2003; 44:1423-1430.
76. Reaven GM. The metabolic syndrome: Requiescat in pace. Clinical Chemistry 2005; 6:931-938.
77. Reilly MP & Rader D. The metabolic syndrome: More than the sum of its parts? Circulation 2003; 108:1546-1551.
78. Reiner Ž & Laganović M. Metabolic syndrome: Relationship between insulin resistance, arterial hypertension and microalbuminuria. Medicus 2004; 13:193-201.
79. Reiner Ž, Mihatov Š, Miličić D, Bergovec M & Planinc D on behalf of the TASPIC-CRO Study Group Investigators. European Journal of Cardiovascular Prevention and Rehabilitation 2006; 13:646-654.
80. Rogers PJ. A healthy body, a healthy mind: long-term impact of diet on mood and cognitive function. Proceedings of the Nutrition Society 2001; 60:135-143.
81. Ryman A. Cholesterol, violent death, and mental disorder. BMJ 1994; 309:421-2.
82. Sevincok L. Buyukozturk A & Dereboy F. Serum lipid concentrations in patients with comorbid generalozed anxiety disorder and major depressive disorder. Can J Psychiatry 2001; 46:68-71.
83. Stamper MJ. Cardiovascular disease and Alzheimer's disease: common links. Journal of Internal Medicine 2006; 260:211-223.
84. Stewart MA & Stewart SG. Serum cholesterol in antisocial personality: a failure to replicate earlier findings. Neuropsychobiology 1981; 7:9-11.
85. Stewart RA, Sharples KJ, North FM, Menkes DB, Baker J, Simes J for the LIPID Study Investigators. Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastin. Arch Intern Med 2000; 160:3144-3152.
86. Šagud M, Mihaljevic-Peleš A, Pivac N, Jakovljević M, Muck-Šeler D. Platelet serotonin and serum lipids in psychotic mania. J Affect Disord. 2007; 97:247-51. Epub 2006 Jul 3.
87. Tancer ME, Stein AM, Moul DE & Uhde TW. Normal serum cholesterol in panic disorder. Biol Psychiazty 1990; 27:99-101.
88. Tanskanen A, Vartiainen E, Tuomilehto J, Viinamaki H, Lehtonen J & Puska P. High serum cholesterol and risk of suicide. Am J Psychiatry 2000; 157:648-650.
89. Thomas AJ, Kalaria RN & O'Brienn JT. Depression and vascular disease: what is the relationship? Journal of Affective Disorders 2004; 79:81-95.
90. Troisi A, Moles A, Panepuccia L, Russo DL, Palla G & Scucchi S. Serum cholesterol levels and mood symptoms in the postpartum period. Psychiatry Research 2002; 109:213-219.
91. Usher K, Foster K & Park T. The metabolic syndrome and schizophrenia: the latest evidence and nursing guidelines for management.. Journal of Psychiatric and Mental Health Nursing 2006; 13:730-734.
92. Valenza M & Cattaneo E. Cholesterol dysfunction in neurodegenerative diseases: Is Huntington's disease in the list? Progress in Neurobiology 2006; 80:165-176.
93. Vikkunen AM. Serum cholesterol in anti-social personality. Neuropsychobiology 1979; 5:27-30.
94. Wardle J. Cholesterol and psychological well-being. Journal of Psychosomatic Research 1995; 39:549-562.
95. Whooley MA. Depression and cardiovascular disease - Healing the broken-hearted. JAMA 2006; 295:2874-2881.
96. Yehuda S. Omega-6/Omega-3 Ratio and Brain-Related Functions. World Rev Nutr Diet 2003; 92:37-56.
97. Zureik M, Courbon D & Ducimetiere P. Serum cholesterol concentration and death from suicide in men: Paris prospective study I. Br Med J 1996; 313:649-651.